The aims of the study were to verify the efficacy and safety of low energy
internal cardioversion (LEIC) in patients with persistent atrial fibrillati
on (AF) and to identify the factors affecting the atrial defibrillation thr
eshold (ADT). Forty-nine patients with persistent (lasting greater than or
equal to 10 days) AF underwent LEIC. In each patient, two 6 Fr custom-made
catheters with large active surface areas were positioned in the coronary s
inus (cathode) and the lateral right wall (anode), respectively, for shock
delivery, and a tetrapolar lead was placed in the right ventricular apes fo
r R wave synchronization. Truncated, biphasic (3 ms + 3 ms), exponential sh
ocks were used, beginning at 50 V and increasing in steps of 50 V until sin
us rhythm had been restored. Mild sedation (diazepam 5 mg IV) was administ
ered to 12 patients. Sinus rhythm nas restored in all the subjects with mea
n voltage and energy levels of 352.0 +/- 80.3 V and 8.2 +/- 3.4 J, respecti
vely. The ADT in patients pretreated with amiodarone (6.4 +/- 1.8 J) was lo
wer than that of patients who had not received any antiarrhythmic drugs (9.
2 +/- 3.7) (P = 0.04). No ventricular arrhythmias were induced by any of th
e atrial shocks, and no other complications were observed. During a mean fo
llow-up of 162.9 +/- 58.7 days, AF recurred in 21 (43%) patients; 71% of th
ese occurred in the first week after cardioversion. LEIC is effective in re
storing sinus rhythm in patients with persistent AF. The technique seems to
be safe and does nor require general anesthesia or, in most cases, sedatio
n. Patients pretreated with amiodarone have lower ADTs.